Skip Navigation

COVID-19 Update

 

Cardiovascular Report Winter 2019

Cardiovascular Report Winter 2019

TAVR at Johns Hopkins

Originally intended for high-risk patients, TAVR is now being offered to low-risk ones as part of a national clinical trial that includes Johns Hopkins.
back to top button